- Country: Germany
- Summary: Open House Biologics Discount Agreements 2024-09 - Golimumab
- DET Ref No: 128993171
- Deadline: 30 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 711232-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The health insurance companies involved pursue the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 SGB V for the active ingredient golimumab. The contract is concluded as part of the open house biologics procedure of the participating health insurance companies: individual negotiations The contents of the contract are not kept, uniform conditions apply. The health insurance companies involved do not guarantee individual contractual partners any exclusivity. The contract term is a maximum of 24 months starting on October 1st, 2024. The contract ends no later than September 30, 2026, regardless from the date of conclusion of the contract. If the patent expires before the above-mentioned end date, the contract ends automatically at the end of the month in which the patent expires. Joining this open house biologics process is possible at any time within the contract period. Due to the existence of industrial property rights With regard to the active ingredient or combination of active ingredients that is the subject of the procedure, the participation and contract documents will only be made available to those pharmaceutical companies that supply medicines for the active ingredient or the combination of active ingredients that are the subject of the procedure offer/market the combination of active ingredients that are the subject of the proceedings or demonstrate to the TK that they intend to offer/market such medicinal products within the term of the contract. All further information can be found in the participation and contract documents remove.
Open house... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINOpen House Biologics Discount Agreements 2024-09 - Golimumab - Germany Tender
The TECHNICIANS' HEALTH INSURANCE, a Government sector organization in Germany, has announced a new tender for Open House Biologics Discount Agreements 2024-09 - Golimumab. This tender is published on GermanyTenders under DET Ref No: 128993171 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-30.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
